Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/LEXICON-PHARMACEUTICALS-I-22283344/news/Lexicon-Enrolls-First-Patient-in-Phase-2b-Progress-Study-of-LX9211-in-Diabetic-Peripheral-Neuropathi-45473023/?utm_source=whatsapp&utm_medium=social&utm_campaign=share